Corrigendum to Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use

( Official Journal of the European Union L 348 of 31 December 2010 )

On Page 97, Article 1, point 22, new text of Article 116, second paragraph:

for:

‘楢 marketing authorisation may also be suspended, revoked or varied where the particulars supporting the application as provided for in Articles 8, 10 or 11 ‘︹�,

read:

‘楢 marketing authorisation may also be suspended, revoked or varied where the particulars supporting the application as provided for in Articles 8, 10, 10a, 10b, 10c or 11 ‘︹�.